#InformaticsInsider (Volume 1)

#InformaticsInsider: The Bioinformatics and Life Science Software Newsletter

#InformaticsInsider (Volume 1)

I am excited to introduce the first edition of my bioinformatics newsletter Informatics Insider. The goal is to keep you informed about the latest trends, breakthroughs, and developments in the field of bioinformatics and life science software. As the industry continues to grow and evolve, it is more important than ever to stay informed with the latest technologies and market trends.

Whether you're a Bioinformatics professional, a researcher, or just have a passion for all things biotech, Informatics Insider is here to provide you with the knowledge and expertise you need to stay ahead of the curve. In each issue, we'll bring you the latest news from the world of Bioinformatics and Life Science Software.

Informatics Insider will cover a range of categories, including:

• Company of the Week
• Candidate of the Week
• Collaboration of the Week
• Informatics News

If you're interested in contributing to an upcoming edition or collaborating on a future project, please don't hesitate to reach out. I'd love to hear from you!

Company of the week

The First Company of the week is Genialis. They have recently completed $13 million in Series A.

Founded in 2015 by CEO Rafael Rosengarten.Genialis are a computational precision medicines company unravelling complex biology to find new ways to address disease. Their mission is to deliver benefit and hope to patients and their families. Their method is to leverage biomedical data and advanced analytics to help pharma companies develop more effective drugs with higher probability of clinical success, and diagnostics companies to deploy tests that lead to better treatment decisions.

Genialis is growing its teams in both the U.S. and Slovenia across business, operations, life science and data science functions and expanding its advisory boards. The company is also investing in R&D collaborations with several leading cancer centre's, hospital groups, and clinical academic labs.

Collaboration of week

Mission Bio X Fulgent Genetics

Mission Bio a pioneer in high-throughput single-cell DNA and multi-omics analysis, on Tuesday announced that it has entered into an agreement with Fulgent Genetics a technology-based company with well-established clinical diagnostic and therapeutic development businesses. Fulgent Genetics is now able to offer single-cell multi-omics on the Tapestri Platform on its fully customizable menu of services, including whole genome, whole exome, RNA sequencing, tumour profiling, methylation sequencing, liquid biopsy, single-cell sequencing, spatial biology, and pathology services to support its growing pharma client demands. Additionally, Fulgent Genetics will evaluate the Tapestri Platform for applications in clinical development to streamline the drug development and approval process.

Candidate of the week

SVP of Sales & BD – Oncology and Genomics – US

• 20+ years of global sales experience
• Responsible for generating and managing over $25M in annual revenue
• Built & executed global commercial strategy across the US and Europe scaling the team from 3- 15+
• DNA cloud platform: 50% annual revenue growth (year 1), 100% annual revenue growth.
• Client network: Biotechnology, Pharmaceuticals

BS- Biotechnology

If you have any interest in the profile above, don't hesitate to reach out, i'd be happy to make an introduction!!

Informatics news

• Ultima Genomics and GENOME INSIGHT INC. Have signed an agreement to collaborate to bring affordable whole genome sequencing solutions to cancer patients.
• Sensible Biotechnologies raises $4.2 million in in pre- seed funding.
• Factorial Biotechnologies is commercialising and intracellular library preparation technology that the company said can 'dramatically simplify' the workflow of single- cell sequencing.
• M2GEN and Absci collaborate to accelerate precision oncology drug discovery with AI.
• AMPEL BioSolutions are developing a molecular test to predict kidney damage in lupus nephritis patients.
• Broad Institute of MIT and Harvard Launches $1k sample to report clinical whole genome sequencing service.
• 23andMe and Morehouse School of Medicine team up on sickle cell carrier awareness.

Do you have any thoughts, or news to share? Join the conversation on LinkedIn by following the hashtag?#InsiderInformatics.

If you're looking to add exceptional talent to your team or seeking new opportunities in the industry, please feel free to reach out to me.

: